Mavens Biotech Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 10.99 Cr
as on 16-11-2024
- Company Age 43 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue -84.35%
(FY 2023)
- Profit 113.03%
(FY 2023)
- Ebitda -11.66%
(FY 2023)
- Net Worth 0.34%
(FY 2023)
- Total Assets 1.17%
(FY 2023)
About Mavens Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 10.99 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mavens Biotech Limited India are Saurav Narang as Company Secretary, Jay Prakash as Ceo, and Abhishek Jain as Cfo. Jay Prakash, Manoj Kumar, Sunita Singhi, and One other member serve as directors at the Company.
- CIN/LLPIN
L17297WB1981PLC034226
- Company No.
034226
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Oct 1981
- Date of AGM
12 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Mavens Biotech?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jay Prakash  | Managing Director | 28-Jan-2022 | Current |
| Saurav Narang | Company Secretary | 02-Jan-2019 | Current |
| Abhishek Jain | CFO | 04-Aug-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Kumar | Director | 01-Oct-2020 | Current |
| Sunita Singhi | Director | 24-Jul-2024 | Current |
| Biswajit Barua | Director | 26-Jul-2023 | Current |
Financial Performance and Corporate Structure Insights of Mavens Biotech.
Mavens Biotech Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 84.35% decrease. The company also saw a substantial improvement in profitability, with a 113.03% increase in profit. The company's net worth moved up by a moderate rise of 0.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mavens Biotech?
In 2023, Mavens Biotech had a promoter holding of 32.04% and a public holding of 67.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shree Tulsi Online Com- LimitedActive 41 years 11 monthsManoj Kumar and Sunita Singhi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mavens Biotech?
Unlock and access historical data on people associated with Mavens Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mavens Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mavens Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
